ClinicalTrials.Veeva

Menu
L

Laurelton Heart Specialist PC | NY Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ziltivekimab
cholesterol
NNC0487-0111
MK-7262
Enlicitide
MK-0616

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials
Locations recently updated

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

Researchers designed a trial medicine called MK-7262 to lower levels of Lp(a) in the blood. Researchers want to learn about giving MK-7262 with anoth...

Enrolling
Lipoprotein(a)
Drug: Enlicitide
Drug: Placebo for enlicitide

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or He...

Enrolling
Obesity
Heart Failure
Drug: NNC0487-0111
Drug: Placebo
Locations recently updated

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Active, not recruiting
Heart Failure
Drug: Placebo
Drug: Ziltivekimab

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/...

Active, not recruiting
Arteriosclerosis
Hypercholesterolaemia
Drug: Enlicitide Decanoate
Drug: Placebo

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Novo Nordisk logo
Exact Sciences Corporation logo
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems